preaﬁco G, et al. Ultrasound guided foam
sclerotherapy of recurrent varices of the great and small saphenous
vein: 5-year follow up. Veins and Lymphatics 2014;3:57-9.
199. Cartee TV, Wirth P, Greene A, et al. Ultrasound-guided foam
sclerotherapy is safe and effective in the management of superﬁcial
venous insufﬁciency of the lower extremity. J Vasc Surg Venous
Lymphat Disord 2021;9:1031-40.
200. Peterson JD, Goldman MP. An investigation into the inﬂuence of
various gases and concentrations of sclerosants on foam stability.
Dermatol Surg 2011;37:12-7.
201. Bai T, Liu Y, Jiang W, et al. A review of sclerosing foam stability in the
treatment of varicose veins. Dermatol Surg 2020;46:249-57.
202. Morrison N, Neuhardt DL. Foam sclerotherapy: cardiac and cerebral
monitoring. Phlebology 2009;24:252-9.
203. Morrison N, Neuhardt DL, Rogers CR, et al. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical
ablation. J Vasc Surg 2008;47:830-6.
204. Willenberg T, Smith PC, Shepherd A, Davies AH. Visual disturbance
following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review. Phlebology 2013;28:
123-31.
205. Gillet JL, Guedes JM, Guex JJ, et al. Side-effects and complications
of foam sclerotherapy of the great and small saphenous veins: a
controlled multicentre prospective study including 1,025 patients.
Phlebology 2009;24:131-8.
206. Todd KL 3rd